ECHO-Chicago: Complex Pediatric Asthma
Target Audience
Learning Objectives
After this activity, participants will be able to:
- Describe EXHALE strategies to reduce asthma-related hospitalizations, emergency department visits, and healthcare costs;
- State how to identify patients with asthma using standard tests for diagnosis and assessment of severity;
- Discuss definitions, history, and investigations related to the diagnosis and monitoring of pediatric asthma;
- Recall common treatment plans for asthma, including pharmacotherapy, environmental modifications, patient and family education, and school-based interventions;
- Review how to monitor asthma symptoms adequately to reduce the effect they have on the children experiencing them;
- Describe common comorbid conditions of asthma and differential diagnoses;
- Discuss problems associated with difficult-to-treat or severe asthma.
- 12.00 AMA PRA Category 1 Credit™
- 12.00 Participation
Session Date | Topic |
2/1/24 | Introduction to ECHO-Chicago, Asthma Epidemiology and Definition – Led by Margarita Guarin, MD & Anna Volerman, MD |
2/8/24 | Asthma Pathogenesis & Clinical Diagnosis – Led by Margarita Guarin, MD |
2/15/24 | Asthma Diagnosis and Learning Spiromety – Led by Margarita Guarin, MD |
2/22/24 | Why Changes in Asthma Treatment? – Led by Margarita Guarin, MD |
2/29/24 | Principles of Treatment & Medication – Led by Margarita Guarin, MD |
3/7/24 | Control of Symptoms and Telemedicine – Led by Anna Volerman, MD |
3/14/24 | Changes in Guidelines for Asthma Treatment – Led by Margarita Guarin, MD |
3/21/24 | Other Treatment Interventions – Led by Margarita Guarin, MD |
3/28/24 | Self-management Education for Patients & Families – Led by Alanna Stinson, MD |
4/4/24 | Comorbidities- Conditions that Co-exist with and/or that Mimic Asthma – Led by Anna Volerman, MD |
4/11/24 | Community Partner Education (i.e. Schools) – Led by Anna Volerman, MD |
4/18/24 | Series Wrap-up and Review of EXHALE - Led by Anna Volerman, MD |
The agenda is subject to change.
WANT TO KNOW MORE?
UNIVERSITY OF CHICAGO COURSE DIRECTOR
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Participant Credit
Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.